ISSN - 0973-0958
https://www.pediatriconcall.com/Journal/images/journal_cover.jpg
   
 
Kocher-Debre Semelaigne Syndrome
Sanjeev Kumar Digra1, Virender Singh1, Shirin Nomani2.
1Department of Pediatrics, Government Medical College, Jammu, JandK, 2Ayush Hospital, Bhubaneshwar, Orissa, India.

Cite this article  Copy Citation
Digra S K, Singh V, Nomani S. Kocher-Debre Semelaigne Syndrome. Pediatr Oncall J. 2009;6: 56-57.

Address for Correspondence
Sanjeev Kumar Digra, C, O Sh. S.D. Thappa, 190- Reshamghar Colony, Jammu {JandK}, India.

Email
sanjeevahsaas@yahoo.co.in

A 15 years old boy came with excessive sluggishness, weakness, sleepiness, poor appetite and cold intolerance for last seven months. On examination he had coarse facial features, rough skin, short neck, dull look, edematous eyelids, broad and short hands and legs as depicted in Figure. His heart rate was 68 per minute, respiration rate 16 per minute, blood pressure 112, 74 mmHg and temperature was 98.4 degree F. Thyroid profile was suggestive of hypothyroidism {T3- 20mg, dl, T4-1.2 mg, dl and TSH- 211iu, ml}.

What is the diagnosis?

 
Kocher Debre Semeiaigne syndrome. In hypothyroidism muscles become hypotonic. A variant of hypothyroidism seen in children and rarely in neonates in whom there occurs generalized muscular pseudo-hypertrophy is known as Kocher-Debre Semelaigne syndrome {1,2}. Similar condition in adults is known as Hoffman’s syndrome {3}. The affected children have an athletic appearance. The exact incidence of this syndrome is not known but it has certainly become rare with the prevention as well as early detection and proper treatment of hypothyroidism in children. Its pathogenesis is also obscure. Incidence of this syndrome is more in boys than girls, children born as a result of consanguineous marriages and hypothyroidism of longer duration and more severity. Muscle biopsies of these patients reveal many chemical and ultra structural changes {1}. Mastaglia et al reported type I and type II fiber atrophy or hypertrophy, myofibre necrosis and regeneration in four cases and in one case prominent core – like areas containing amorphous granulo-filamentous material in patient with hypothyroidism. The findings in their series of cases illustrate the clinical and histopathological heterogeneity of patients with hypothyroid myopathy. However this condition is completely reversible with use of thyroxin {4}. On review after six months our patient on thyroxin showed improvement with regression of muscular hypertrophy.

References:
1. LaFranchi. Disorders of the thyroid gland. In: Kliegman RM, Behrman RE, Jenson HB, Stanton BF {eds} Nelson Textbook of Pediatrics, 18th Edn. : Elsevier, New Delhi. 2008, pp. 2316- 40.
2. Ghosh JB. Kocher Debre Semelaigne syndrome in a neonate. Indian Pediatr 1988, 25: 1018-1019.
3. Brown RH, Mendell JR. Muscular dystrophies and other muscle diseases. In: Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL {eds} Harrison’s Principles of Internal Medicine, 16th Edn. : McGraw-Hill, New Delhi. 2005, pp 2527-2540.
4. Mastaglia FL, Ojeda VJ, Sarnat HB, Kakulas BA. Myopathies associated with hypothyroidism : a review based upon 13 cases. Aust N Z J Med 1988, 18: 799-806.

E-published: August 2009 Vol 6 Issue 8 Art # 46
 
Funding: None
 
Conflict of Interest: None
 
Cite this article as :
Digra S K, Singh V, Nomani S. Kocher-Debre Semelaigne Syndrome. Pediatr Oncall J. 2009;6: 56-57.
ask a doctor
Ask a Doctor
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License
Disclaimer: The information given by www.pediatriconcall.com is provided by medical and paramedical & Health providers voluntarily for display & is meant only for informational purpose. The site does not guarantee the accuracy or authenticity of the information. Use of any information is solely at the user's own risk. The appearance of advertisement or product information in the various section in the website does not constitute an endorsement or approval by Pediatric Oncall of the quality or value of the said product or of claims made by its manufacturer.
0 0 0 0 0 0 0 0 0 0 0 0 0 0 0 0